Progress in understanding the role of HSP90 overexpression in cancer progression and the differences between HSP90 in normal cells and HSP90 in cancerous cells has made HSP90 a target chaperone protein for a cancer therapy drug. This evidence concerns the gene HSP90AB1 and cancer.